Cue Biopharma, Inc. (CUE) Tops Q1 EPS by 4c

Cue Biopharma, Inc. (NASDAQ: CUE) reported Q1 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $733.33 thousand.

For earnings history and earnings-related data on Cue Biopharma, Inc. (CUE) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Deutsche Bank monitors UK auto sales as Chinese exports grow
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance